that enables non-professional writers to purchase freelance editing services while maintaining a high level of control over the quality of the received services. Team: Jeff Wellman, finance and operations management and the Hinman CEOs Program; Bernard Wong, bioengineering and the Hinman CEOs Program; Esmaeel Paryavi, bioengineering and the Hinman CEOs Program.Trade Assurance International has developed HD Trade Services, a risk-mitigating, high-definition video platform for the quality control verification of high-value goods traded internationally. Team: Daniel Sperling-Horowitz, finance and the Hinman CEOs Program; Sam Winter, civil engineering and the Hinman CEOs Program; David Wortman.
Judges in the high-technology/biotechnology category included: Jonathan Aberman, Managing Director, Amplifier Ventures; Joe DelGuercio, Managing Director, CNF Investments; Kiran Hebbar, Partner, Valhalla Partners; Charles Montague, Program Manager, Biotechnology Development Programs, Maryland Biotechnology Center; and Janet Yang, Principal, Novak Biddle Venture Partners.
Judges for the undergraduate category included: David Kirsch, Associate Professor, Robert H. Smith School of Business; Amy Millman, President, Springboard Enterprises; Mark Rothman, Founder and CEO, MYTA; Todd Stave, CEO, Entrepreneur and Salesman; and Sebastian Traeger, Founder, Razoo.
The University of Maryland $75K Business Plan Competition is administered by the Maryland Technology Enterprise Institute (Mtech), an initiative of the A. James Clark School of Engineering. Previous winners include five multi-million dollar ventures, including Squarespace and Lurn, both of which were named to the Inc. 500 list for the second straight year.
The competition encourages students, faculty and researchers at the University of Maryland to leverage their talent and ideas to create tomorrow's leading companies. The competition process, its mentors, partne
Page: 1 2 3 4 Related medicine technology :1
|SOURCE Maryland Technology Enterprise Institute|
Copyright©2010 PR Newswire.
All rights reserved
. Data on DermTechs Non-invasive Test for Melanoma Are Published in the British Journal of Dermatology2
. Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development3
. Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil4
. Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine5
. Immtech Announces Posting of Annual Shareholders Meeting Presentation6
. Immtech Reports Fiscal Second Quarter 2008 Results7
. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference8
. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials9
. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial10
. Chinese SFDA Grants Immtech Fast Track Status11
. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness